New salts of 3-(2,2,2-trimethylhydrazinium)propionate as well as method for manufacture and pharmaceutical compositions on their basis are described. The common formulae of the compound is X-(CH3)3N+NHCH2CH2COOH where X- is an acid anion chosen from group of pharmaceutically acceptable acids. Particularly preferable for manufacture of various medicinal formulations are acid salts of fumaric acid,phosphoric acid, orotic acid, oxalic acid, maleic acid, pamoic acid as well as 3-(2,2,2-trimethylhydrazinium)propionate orotate and galactarate having prolonged effect. All pharmaceutical formulationscan be administered orally, parenterally, subcutaneously, transdermally and rectally.